Oosthuizen Johannes Jacobus

President, U.S. Market

Merck & Co., Inc.

US, Kenilworth [HQ]

CIK 1916310

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

24,270,949

Price per Share :

$100.70

Equivalence :

$2,444,084,564.30

M

Form 4

24,270,949 Shares After Transaction

Value : $3,094,788,706.99

$116,289.12

Transaction Date : 05/04/24
- Footnotes
- Form 4
Footnotes:
#1 Holdings include shares acquired in dividend reinvestment transactions.
F

Form 4

23,820,949 Shares After Transaction

Value : $3,037,409,206.99

$57,379.50

Transaction Date : 05/04/24
- Footnotes
- Form 4
Footnotes:
#1 Holdings include shares acquired in dividend reinvestment transactions.
A

Form 4

21,349,345 Shares After Transaction

Value : $2,549,752,273.35

$374,174.19

Transaction Date : 01/22/24
- Footnotes
- Form 4
Footnotes:
#1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.

#2 Holdings include shares acquired in dividend reinvestment transactions.
M

Form 4

28,122,345 Shares After Transaction

Value : $2,119,299,919.20

$510,413.28

Transaction Date : 02/02/24
- Footnotes
- Form 4
Footnotes:
#1 Holdings include shares acquired in dividend reinvestment transactions.
M

Form 4

35,167,345 Shares After Transaction

Value : $2,592,888,346.85

$519,427.85

Transaction Date : 02/02/24
- Footnotes
- Form 4
Footnotes:
#1 Holdings include shares acquired in dividend reinvestment transactions.

Get PRO Today.

PRO unlocks 2 more insider transactions made by Oosthuizen Johannes Jacobus

Start Free PRO trial Subscribe to PRO

NYSE

United States

Kenilworth

Healthcare

Drug Manufacturers—General